Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated whole genome microarray analysis and immunohistochemical assay identifies COL11A1, GJB2 and CTRL as predictive biomarkers for pancreatic cancer
Authors
Keywords
-
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-06
DOI
10.1186/s12935-018-0669-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
- (2018) Ashton C. Berger et al. CANCER CELL
- Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
- (2018) Hideaki Tsuyoshi et al. CANCER SCIENCE
- A novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs
- (2018) Mongkol Pongsuchart et al. CANCER SCIENCE
- Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer
- (2018) Haoyi Jin et al. CANCER SCIENCE
- Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma
- (2017) Wen Cheng et al. JOURNAL OF NEUROSURGERY
- Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma
- (2016) Wen Cheng et al. JOURNAL OF NEUROSURGERY
- Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
- (2016) Wen Cheng et al. NEUROLOGY
- Expansion of the Gene Ontology knowledgebase and resources
- (2016) NUCLEIC ACIDS RESEARCH
- Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium
- (2016) Peng Liu et al. Scientific Reports
- Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer
- (2014) Nestor F. Esnaola et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature
- (2014) Josie Hayes et al. Molecular Oncology
- Emerging role of the KRAS-PDK1 axis in pancreatic cancer
- (2014) Riccardo Ferro WORLD JOURNAL OF GASTROENTEROLOGY
- Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
- (2013) H. Fensterer et al. ANNALS OF ONCOLOGY
- Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
- (2013) Jung Yong Hong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DAVID-WS: a stateful web service to facilitate gene/protein list analysis
- (2012) X. Jiao et al. BIOINFORMATICS
- Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
- (2012) Timothy R. Donahue et al. CLINICAL CANCER RESEARCH
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started